Table 3.
Clinical outcome-FET cycles
| Variables | Group A (GnRHa) (n=92) |
Group B (hCG) (n=101) |
p-value |
|---|---|---|---|
| FET cycles attempted (365) | 170 | 195 | - |
| FET cycles cancelled n(%) | (21/170) 12.3 | (26/195) 13.3 | 0.776 |
| FET cycles with cleavage/blastocyst transfers a. cleavage n (%) b. blastocyst n (%) |
(46/149) 30.8 (103/149) 69.1 |
(75/169) 44.3 (94/169) 55.6 |
0.013 0.013 |
| Mean number of embryos thawed a. cleavage b. blastocyst |
3.02±0.57 2.15±0.53 |
3.19±0.48 2.16±0.40 |
0.079 0.881 |
| Survival rate n (%) a. cleavage n (%) b. blastocyst n (%) |
(123/142) 86.6 (198/221) 89.5 |
(209/239) 87.4 (181/203) 93.3 |
0.815 0.894 |
| Mean number of embryos transferred a. cleavage b. blastocyst |
2.62±0.61 1.92±0.3 |
2.79±0.41 1.93±0.26 |
0.068 0.803 |
| Clinical pregnancy/ET n (%) | (79/149) 53 | (70/169) 41.4 | 0.039 |
| Implantation rate n (%) | (94/321) 29.2 | (82/390) 21 | 0.011 |
| Miscarriage rate n (%) | (16/149) 10.73 | (20/169) 11.83 | 0.757 |
| Live birth per ET n (%) | (51/149) 34.2 | (37/169) 21.89 | 0.014 |
| Singleton births n (%) | (38/79) 48.1 | (25/70) 35.7 | 0.127 |
| Multiple births n (%) | (13/79) 16.4 | (12/70) 17.1 | 0.909 |
| Cumulative live birth rate n (%) | (51/92) 55.43 | (37/101) 36.63 | 0.009 |
expressed as number (percentage). p<0.05= statistically significant